0001363585-12-000006.txt : 20120621 0001363585-12-000006.hdr.sgml : 20120621 20120621185726 ACCESSION NUMBER: 0001363585-12-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120620 FILED AS OF DATE: 20120621 DATE AS OF CHANGE: 20120621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brusegard David CENTRAL INDEX KEY: 0001516920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 12920679 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO STATE: A6 ZIP: M5J 2G2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-06-20 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001516920 Brusegard David 33 HARBOUR SQUARE TORONTO A6 M5J 2G2 ONTARIO, CANADA 0 1 0 0 Chief Operating Officer Common Stock Purchase Option (right to buy) 0.001 2012-06-20 4 A 0 546448 0 A 2012-06-20 2017-06-20 Common Stock 546448 546448 D On June 6, 2012, the Board of Directors of the issuer granted the reporting person options to purchase 546,448 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 20, 2012. The grant was made pursuant to the terms of the issuer's 2006 stock plan. David Brusegard 2012-06-21